Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)

• Status: Completed
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of current study is to evaluate the efficacy and safety of oral Ibuprofen in term 20-28 days old newborn referred to Bandarabbas children' hospital in 2011.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hormozgan University of Medical Sciences
• Treatments: Ibuprofen

Criteria

Inclusion Criteria:

• Term newborn (37 weeks of gestation or more)

• Age between 20-28 days

• confirmed diagnosis of PDA by echocardiography by pediatric cardiologist

Exclusion Criteria:

• Asphyxia

• Hemorrhage

• Platelet count < 150000

• renal or gastrointestinal malformations

• associated congenital heart disease